Emerging pharmacotherapies for COVID-19 - ScienceDirect
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
JKMS :: Journal of Korean Medical Science
Schematic representation of ritonavir's action. Abbreviations: CYP3A4,... | Download Scientific Diagram
Infectious diseases | Nature Reviews Drug Discovery
Antibiotics | Free Full-Text | Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark? | HTML
Drug repurposing approach to fight COVID-19 | SpringerLink
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 - ScienceDirect
Revealing the binding and drug resistance mechanism of amprenavir, indinavir, ritonavir, and nelfinavir complexed with HIV-1 protease due to double mutations G48T/L89M by molecular dynamics simulations and free energy analyses - Physical
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2 | EMBO Molecular Medicine
Mechanism of action of antiretroviral drugs through the life cycle of... | Download Scientific Diagram
Lopinavir - an overview | ScienceDirect Topics
Mechanism of Hydroxychloroquine, Azithromycin, Lopinavir/Ritonavir,... | Download Scientific Diagram
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
Biovista Vizit - Lopinavir/Ritonavir mechanism of action analysis in COVID-19
Viren Kaul, MD on Twitter: "Cao: Drug targets for Rx of #COVID19 - prevent Endo some mediated viral entry: Chloroquine - inhibit RNA synthesis: Remdesivir - IL-6 anatagonists to prevent downstream cytokine
IJMS | Free Full-Text | Existing Drugs Considered as Promising in COVID-19 Therapy | HTML
HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect
Life | Free Full-Text | Statins in COVID-19 Therapy | HTML
The human immunodeficiency virus protease inhibitor ritonavir is poten | OTT
Frontiers | Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives | Molecular Biosciences
Frontiers | Progress in the Research and Development of Anti-COVID-19 Drugs | Public Health
